How big is the United States Self-Monitoring Blood Glucose Market?

The United States Self-Monitoring Blood Glucose Market size is expected to reach USD 7.62 billion in 2024 and grow at a CAGR of 6.40% to reach USD 10.38 billion by 2029. Read More

What is the current United States Self-Monitoring Blood Glucose Market size?

In 2024, the United States Self-Monitoring Blood Glucose Market size is expected to reach USD 7.62 billion. Read More

Who are the key players in United States Self-Monitoring Blood Glucose Market?

Abbott Diabetes Care, Ascensia Diabetes Care, Roche Diabetes Care, Arkray Inc. and LifeScan Inc. are the major companies operating in the United States Self-Monitoring Blood Glucose Market. Read More

What years does this United States Self-Monitoring Blood Glucose Market cover, and what was the market size in 2023?

In 2023, the United States Self-Monitoring Blood Glucose Market size was estimated at USD 7.16 billion. The report covers the United States Self-Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the United States Self-Monitoring Blood Glucose Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

United States Self-Monitoring Blood Glucose Market Share

Statistics for the 2023 & 2024 United States Self-Monitoring Blood Glucose market share, created by Mordor Intelligence™ Industry Reports. United States Self-Monitoring Blood Glucose share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of United States Self-Monitoring Blood Glucose Industry

The United States self-monitoring blood glucose market is moderately fragmented, with a few significant and other generic players. Manufacturers like i-Sens, Abbott, LifeScan, and Ascensia occupy a major share.